γ‐Oryzanol Ameliorates Depressive Behavior in Ovariectomized Mice by Regulating Hippocampal Nitric Oxide Synthase: A Potential Therapy for Menopausal Depression
Authors:
Open Access
- 6 December 2023
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 68 (3) , e2300253
Abstract
Scope: Depression is a severe mental condition, common among menopausal women. γ‐Oryzanol (ORY) has various biological properties; however, the effect of ORY on menopausal depression and its underlying mechanisms have not been investigated.Methods and results: ORY is orally administered to ovariectomized (OVX) mice for 20 weeks. ORY administration results in lower immobility time in the tail suspension and forced swim test and increases locomotor activity in the open field test. In the primary hippocampal neurons and hippocampi of OVX mice, ORY treatment increases nitric oxide (NO) production and neuronal NO synthase (nNOS) expression. Further, the phosphorylation of extracellular signal‐regulated kinase (ERK), cAMP response element‐binding protein (CREB), and tropomyosin receptor kinase B, along with the expression of brain‐derived neurotrophic factior (BDNF), is upregulated. These stimulatory effects of ORY are diminished by treatment with estrogen receptor β (ERβ) antagonist. ORY similarly interacts with ERβ in the molecular docking analysis. Moreover, intracerebroventricular injection of 7‐nitroindazole, a nNOS inhibitor, abolishes the antidepressant effects of ORY.Conclusions: The results indicate that ORY attenuates depressive behavior in OVX mice by upregulating ERβ‐mediated hippocampal nNOS expression and activating the ERK‐CREB‐BDNF signaling networks. The findings suggest that ORY is a potential therapeutic agent for attenuating menopausal depression.Keywords
This publication has 55 references indexed in Scilit:
- Estrogen receptor modulatory effects of germinated brown rice bioactives in the uterus of rats through the regulation of estrogen-induced genesDrug Design, Development and Therapy, 2013
- Hippocampal nitric oxide contributes to sex difference in affective behaviorsProceedings of the National Academy of Sciences, 2012
- γ-Oryzanol Reduces Adhesion Molecule Expression in Vascular Endothelial Cells via Suppression of Nuclear Factor-κB ActivationJournal of Agricultural and Food Chemistry, 2012
- Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trialsBreast Cancer Research and Treatment, 2011
- Hippocampal Neuronal Nitric Oxide Synthase Mediates the Stress-Related Depressive Behaviors of Glucocorticoids by Downregulating Glucocorticoid ReceptorJournal of Neuroscience, 2011
- Neuronal Nitric Oxide Synthase Alteration Accounts for the Role of 5-HT1AReceptor in Modulating Anxiety-Related BehaviorsThe Journal of Neuroscience, 2010
- Subacute oral administration of low dose 17 β -estradiol or 17 α -ethinyl estradiol does not markedly alter the immune system of young adult and aged C57BL/6 miceToxicological & Environmental Chemistry, 2008
- ERβ-Selective Estrogen Receptor Modulators Produce Antianxiety Behavior when Administered Systemically to Ovariectomized RatsNeuropsychopharmacology, 2005
- 17β-Estradiol increases inducible nitric oxide synthase expression in macrophagesBiochemical and Biophysical Research Communications, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001